Nomura Asset Management
AMRX icon

Nomura Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Nomura Asset Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$934K Hold
53,978
– – ﹤0.01% 757
2026
Q1 		$671K Hold
53,978
– – ﹤0.01% 798
2025
Q4 		$680K Hold
53,978
– – ﹤0.01% 786
2025
Q3 		$540K Hold
53,978
– – ﹤0.01% 806
2025
Q2 		$437K Buy
+53,978
New +$407K ﹤0.01% 818

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Nomura Asset Management's AMRX Position: Q2 2026 in Review

Nomura Asset Management held its Amneal Pharmaceuticals (AMRX) position steady in Q2 2026 at 53,978 shares worth $934K. The position accounts for ﹤0.01% of the portfolio, ranked #757.

Nomura Asset Management first reported a position in AMRX in Q2 2025 and has held it in 5 quarters since. 306 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Nomura Asset Management held 53,978 shares of Amneal Pharmaceuticals worth $934K as of Q2 2026.
  • Nomura Asset Management left its Amneal Pharmaceuticals share count unchanged in Q2 2026.
  • Amneal Pharmaceuticals made up ﹤0.01% of Nomura Asset Management's portfolio in Q2 2026, its #757 holding.
  • Nomura Asset Management first reported a position in Amneal Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 306 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Nomura Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.